MARKETS
Markets Overview
Our hypothermic storage and cryopreservation media products
are used to store, transport, and preserve biologic material
including cells, tissues, and organs. We market our products
worldwide to several distinct market segments.
Our customers include academic research institutions, clinical
research laboratories and medical centers, and commercial
companies engaged in product and services development in the
market segments listed at the left side of this page.
PA Consulting Group, a global consulting firm with expertise in
life sciences and healthcare, estimates the worldwide market for
media to preserve cells, tissues, and organs for research and
clinical applications will grow from $200 million in 2007 to
more than $300 million by 2011.
Our strategic plan includes executing specific programs designed
to enable us to capture a significant share of the demand for
preservation media in our target markets.
Read about the superior results our products enabled here.
BioLife Business Development News
BioLife Solutions Grants Product License to Centocor Research and Development, Inc.
BioLife announces HypoThermosol¨
supply and license agreement with Intercytex
BioLife Solutions Announces Exclusive CryoStor™ Supply Agreement
with the New England
Cryogenic Center